Skip to content

Patients › Hand

Viêm khớp khớp ngón tay thứ hai

Osteoarthritis and inflammatory arthritis of the PIP joint — non-operative and surgical options.

Updated Aug 2026
Một minh họa vẽ tay của một khớp ngón tay giữa bị thoái hóa và mòn.
Một bàn tay bị ảnh hưởng bởi viêm khớp — sưng và biến dạng rõ rệt ở các khớp ngón tay. PhilipPirrip / Wikimedia Commons, CC BY 4.0

Trang này được dịch bằng máy và chưa được bác sĩ kiểm tra. Bản tiếng Anh là bản chính thức.

Những gì bạn đang cảm thấy

Bạn có thể cảm thấy đau ở khớp giữa của ngón tay. Điều này thường do viêm xương khớp do hao mòn hoặc tổn thương từ một chấn thương trước đó gây ra. Cơn đau có thể sâu và âm ỉ. Nó cũng có thể cảm thấy sắc nhọn khi bạn cử động ngón tay.

Cơn đau thường trở nên nặng hơn sau khi bạn sử dụng tay. Các nhiệm vụ như nâng đồ tạp hóa, mở lọ hoặc đánh máy có thể khiến cơn đau đập thình thịch. Bạn có thể nhận thấy sự cứng khớp khi vừa thức dậy vào buổi sáng. Sự cứng khớp này thường giảm bớt sau khi bạn cử động tay trong vài phút. Tuy nhiên, khớp có thể cảm thấy cứng lại sau một ngày dài hoạt động.

Các hoạt động hàng ngày có thể trở nên khó khăn. Bạn có thể gặp khó khăn khi nhét áo vào quần hoặc với ra sau lưng để cài áo ngực. Các động tác cầm nắm đơn giản, như cầm cốc hoặc xoay tay nắm cửa, có thể gây khó chịu. Một số bệnh nhân nhận thấy rằng nằm nghiêng gây áp lực lên khớp, khiến họ khó nghỉ ngơi hơn.

Trong một số trường hợp, khớp có thể không duỗi thẳng hoàn toàn. Điều này được gọi là co duỗi (flexion contracture). Bạn có thể nhận thấy ngón tay của mình vẫn hơi cong. Nắn bột tuần tự có thể giúp sửa chữa tình trạng này ở những bệnh nhân được chọn lọc.

Nếu cơn đau của bạn nghiêm trọng và ngăn cản bạn thực hiện các hoạt động bình thường, phẫu thuật có thể là một lựa chọn. Thay khớp PIP là một lựa chọn đáng tin cậy cho viêm xương khớp thoái hóa, sau chấn thương hoặc viêm. Mục tiêu của nó là giảm đau và khôi phục chức năng.

Bạn nên biết rằng tầm vận động có thể thay đổi theo thời gian. Các nghiên cứu cho thấy rằng khả năng vận động có thể suy giảm theo thời gian theo dõi dài hơn. Mặc dù vậy, nhiều bệnh nhân báo cáo giảm đau tốt và sự hài lòng. Hầu hết mọi người trở lại làm việc sau thời gian trung vị là 8 tuần.

Bác sĩ phẫu thuật của bạn sẽ đánh giá xem bạn có phải là ứng viên phù hợp hay không. Điều trị ngón tay dài có thể là một chống chỉ định tương đối. Việc chẩn đoán sớm các tình trạng như viêm khớp dạng thấp là rất quan trọng. Việc giới thiệu đến chuyên gia có thể cải thiện kết quả điều trị.

Những gì thực sự đang xảy ra

Các khớp ở bàn tay của bạn được thiết kế để chuyển động một cách trơn tru. Một lớp sụn mỏng đóng vai trò như một bộ giảm xóc giữa các xương. Trong bệnh viêm xương khớp, lớp phủ này bị mòn đi. Các xương bắt đầu cọ xát vào nhau. Điều này gây ra đau đớn và cứng khớp.

Các cơ và gân ở bàn tay của bạn hoạt động như một đội nhóm. Chúng bắc cầu qua nhiều khớp để tạo ra chuyển động. Khi viêm khớp phát triển, sự phối hợp này bị phá vỡ. Bàn tay của bạn mất đi sức mạnh. Các nghiên cứu cho thấy phụ nữ bị viêm khớp bàn tay có lực nắm grip thấp hơn 30% so với phụ nữ khỏe mạnh. Bạn có thể thấy khó khăn hơn khi cầm nắm đồ vật hoặc thực hiện các công việc hàng ngày.

Khi bệnh tiến triển, các ngón tay của bạn có thể không di chuyển hết phạm vi chuyển động. Bạn có thể nhận thấy cung chuyển động nhỏ hơn khi cố gắng nắm tay lại hoặc cầm nắm đồ vật. Các gân và các cấu trúc xung quanh thay đổi hình dạng. Những thay đổi này thường là nguyên nhân chính gây ra biến dạng ngón tay, đặc biệt là ở các giai đoạn đầu.

Tại gốc ngón tay cái, khớp phải chịu các lực căng độc đáo. Các lực cắt nén tác động lên khớp này theo thời gian. Điều này có thể dẫn đến viêm xương khớp do hao mòn ở khớp gian bàn ngón cái (trapeziometacarpal joint). Các dây chằng ổn định khớp này trở nên kém hiệu quả. Sự mất ổn định này góp phần gây ra đau đớn và mất chức năng mà bạn cảm thấy ở gốc ngón tay cái.

Hiểu được những thay đổi cơ học này giúp giải thích các triệu chứng của bạn. Cơn đau đến từ ma sát xương trên xương và tình trạng viêm. Sự cứng khớp đến từ những thay đổi cấu trúc ở các gân và khớp. Bác sĩ phẫu thuật của bạn sử dụng kiến thức này để lập kế hoạch điều trị. Mục tiêu là khôi phục chuyển động trơn tru và giảm đau.

Những gì chúng tôi có thể làm về vấn đề này

Tại Bệnh viện Tư nhân Mater Rockhampton, Tiến sĩ Kieran Hirpara tiếp cận tình trạng này bằng cách điều trị phù hợp với nhu cầu hàng ngày của bạn. Chúng tôi bắt đầu với các phương pháp ít xâm lấn nhất. Bạn có thể thử thay đổi cách sử dụng bàn tay để tránh các cử động gây đau. Các bài tập nhẹ nhàng giúp duy trì tính linh hoạt của khớp và tăng cường các cơ xung quanh. Chúng tôi thường khuyên dùng nẹp để hỗ trợ khớp trong các hoạt động. Hãy dành ít nhất sáu tuần để xem các biện pháp này có hiệu quả hay không.

Nếu tình trạng đau vẫn tiếp diễn, chúng tôi sẽ thảo luận về các lựa chọn điều trị bằng thuốc. Các loại thuốc giảm đau không kê đơn có thể làm giảm sự khó chịu. Các loại thuốc chống viêm giúp làm giảm sưng trong khớp. Chúng tôi có thể thực hiện tiêm để mang lại sự giảm đau kéo dài hơn. Tiêm cortisone làm giảm viêm và có thể kéo dài trong vài tháng. Tiêm axit hyaluronic nhằm mục đích bôi trơn khớp, mặc dù hiệu quả có thể khác nhau. Tiêm huyết tương giàu tiểu cầu sử dụng các thành phần máu của chính bạn để hỗ trợ quá trình lành vết thương, nhưng bằng chứng về hiệu quả đối với các khớp ngón tay vẫn đang được nghiên cứu thêm. Những phương pháp điều trị này giúp kiểm soát các triệu chứng nhưng không thể đảo ngược bệnh viêm khớp.

Khi các phương pháp điều trị bảo tồn không còn mang lại sự cải thiện đáng kể, chúng tôi sẽ xem xét phẫu thuật. Đây là một quyết định chung dựa trên mức độ đau và chức năng của bạn. Chúng tôi xem xét liệu bệnh viêm khớp có ảnh hưởng đến khả năng làm việc hoặc tham gia các hoạt động hàng ngày của bạn hay không. Nếu bạn đủ điều kiện, chúng tôi có thể thảo luận về thay khớp hoặc hợp nhất khớp. Các thủ thuật này nhằm mục đích giảm đau và khôi phục sự ổn định. Chúng tôi sẽ xem xét các rủi ro và lợi ích với bạn trước khi tiến hành.

Những điều cần biết

Tiên lượng của bạn sau khi thay khớp ở ngón tay phụ thuộc vào tình trạng cụ thể và khả năng phục hồi của cơ thể bạn. Đối với nhiều bệnh nhân mắc viêm xương khớp do hao mòn, thủ thuật này mang lại giảm đau đáng tin cậy và lâu dài. Bạn có thể mong đợi khớp vẫn ổn định và hoạt động tốt trong nhiều năm. Các nghiên cứu cho thấy giảm đau tốt và sự hài lòng tổng thể được duy trì trong ít nhất hai năm sau phẫu thuật. Một số bệnh nhân báo cáo rằng họ hầu như không còn đau và hoạt động tốt ngay cả sau nhiều thập kỷ.

Quá trình phục hồi diễn ra dần dần. Hầu hết bệnh nhân trở lại làm việc sau thời gian trung bình là 8 tuần. Trong thời gian này, bạn cần tuân thủ chặt chẽ lời khuyên của bác sĩ phẫu thuật để giảm thiểu biến chứng. Giảm thiểu các vấn đề sau phẫu thuật là chìa khóa để quá trình phục hồi suôn sẻ và giảm chi phí chăm sóc sức khỏe. Mặc dù bạn có thể có phạm vi vận động tốt ban đầu, hãy lưu ý rằng chuyển động của khớp có thể suy giảm theo thời gian. Đây là một xu hướng đã biết ở một số loại implant, đặc biệt là những loại được sử dụng ở khớp liên đốt gần (proximal interphalangeal joint).

Nếu không được điều trị, viêm xương khớp ở khớp này thường dẫn đến đau dai dẳng và cứng khớp. Các lựa chọn quản lý khác nhau. Trong một số trường hợp, các phương pháp không phẫu thuật như nẹp cố định tuần tự có thể giúp cải thiện tình trạng cứng khớp ở một số bệnh nhân được chọn. Đối với những người khác, thay khớp vẫn là một lựa chọn tốt và đáng tin cậy cho viêm xương khớp có triệu chứng. Cần lưu ý rằng việc điều trị ngón tay dài có thể là một chống chỉ định tương đối đối với phẫu thuật này, nghĩa là nó có thể không phải là lựa chọn tốt nhất cho mọi người. Các yếu tố như tiểu đường hoặc kinh nghiệm của bác sĩ phẫu thuật cũng có thể ảnh hưởng đến nguy cơ biến chứng của bạn.

Bác sĩ phẫu thuật của bạn sẽ thảo luận xem bạn có phải là ứng viên phù hợp hay không dựa trên tình huống lâm sàng cụ thể của bạn. Mục tiêu là giảm đau và duy trì chức năng. Mặc dù kết quả nói chung là tích cực, nhưng kết quả cá nhân có thể khác nhau. Bạn nên có những kỳ vọng thực tế về tuổi thọ của implant và khả năng xảy ra những thay đổi trong chuyển động của khớp trong tương lai. Việc theo dõi định kỳ đảm bảo bác sĩ phẫu thuật có thể giám sát tiến triển của bạn và giải quyết mọi lo ngại sớm.

Khi nào cần gặp bác sĩ

Hãy yêu cầu đánh giá bởi chuyên gia nếu bạn có đau dai dẳng ở khớp ngón tay giữa không cải thiện khi nghỉ ngơi. Hãy tìm kiếm chăm sóc y tế nếu bạn nhận thấy yếu, mất ổn định, hoặc nếu khớp bị khóa hoặc đột ngột mất lực. Liên hệ với bác sĩ của bạn nếu các triệu chứng ảnh hưởng đến giấc ngủ hoặc công việc của bạn, hoặc nếu bạn trải qua tình trạng xấu đi đột ngột. Phẫu thuật thay khớp PIP được chỉ định cho viêm xương khớp hoặc viêm khớp sau chấn thương. Đây là một lựa chọn đáng tin cậy cho viêm khớp thoái hóa, sau chấn thương hoặc viêm khớp trong bối cảnh lâm sàng phù hợp. Chúng tôi đề xuất điều trị này một cách ngoại lệ nếu viêm khớp gây ra đau chức năng làm giảm khả năng lao động. Chẩn đoán sớm và quản lý đúng cách có thể giúp bảo tồn chức năng bàn tay của bạn.


Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Overview

  • Primary proximal interphalangeal joint (PIPJ) utilization for osteoarthritis has increased, while revision PIPJ utilization has decreased [1].
  • Surgery performed better than collagenase at early and 2-year follow-up in PIP joints [2].
  • PIPJ arthrodesis has very few contraindications and an excellent overall success rate, making it an excellent option for surgical management of PIPJ arthritis [3].
  • Reoperations following primary nonconstrained PIP joint arthroplasties are common [5].
  • Extensor mechanism dysfunction is the most frequent cause of reoperation following primary nonconstrained PIP joint arthroplasty [5].
  • Clinical outcomes for PIP joint replacements with pyrocarbon implants are variable despite substantially good survivorship [7].
  • The survival of pyrocarbon PIP joint arthroplasty was 85% at 5 years of follow-up [10].
  • Pyrocarbon PIP joint arthroplasty is associated with high patient satisfaction [10].
  • PIP joint denervation provides durable, effective pain relief with high patient satisfaction despite osteoarthritis progression [11].
  • PIP joint denervation supports its consideration as a surgical option for symptomatic PIP joint osteoarthritis [11].
  • Ultimate salvage for a failed PIP joint arthroplasty may require arthrodesis or even amputation [12].
  • Treatment of the long finger may be a relative contraindication to PIPJ arthroplasty [16].
  • Reoperations following primary non-constrained PIP arthroplasties are common [18].
  • Pyrocarbon PIPJ replacement is a safe and effective treatment for arthritis of the PIPJ [20].
  • Pyrocarbon PIPJ replacement provides excellent pain relief [20].
  • Pyrocarbon PIPJ replacement increases the arc of motion by more than double the preoperative range [20].

Anatomy & Pathophysiology

  • Maintaining concentric reduction of the PIP joint is a main goal in treating PIP joint complications [4].
  • Restoring joint stability is a main goal in treating PIP joint complications [4].
  • Facilitating early range-of-motion exercises is a main goal in treating PIP joint complications [4] [6].
  • Maintaining motion and function following trauma and/or surgery of the PIP joint remains very challenging [6].
  • Proper biomechanics of a joint must be restored to achieve full, functional range of motion [28].
  • The anatomy of the PIPJ remains a subject of ongoing investigation [29].
  • Evolving understanding of the biomechanical properties of the PIPJ will continue to improve treatment and reconstructive designs [29].
  • Hand therapy programs for the PIP joint must address the specific disorder, timing of injury, and phases of healing to prevent stiffness and dysfunction [30].
  • Stiffness of the PIP joint is a challenging problem that may be successfully treated under the guidance of a hand therapist [31].
  • Suboptimal treatment of intra-articular fractures typically leads to functional impairment of the hand [33].
  • It is more difficult to maintain posture for the ring and little fingers due to deforming forces [35].
  • Implant fractures did not significantly affect upper limb function [39].
  • Establishment of normative values for soft-tissue redundancy may enable surgeons to explain the lack of progress after surgical joint release [40].
  • Establishment of normative values for soft-tissue redundancy may enable surgeons to determine progress with hand therapy [40].
  • Establishment of normative values for soft-tissue redundancy may enable surgeons to choose the optimal timing of surgical intervention once soft-tissue equilibrium is achieved [40].
  • Simulated arthrodesis of the middle finger affected grip strength more than that of the ring finger [41].
  • Patients with greater hand function preoperatively may be at higher risk of revision surgery after silicone metacarpophalangeal joint arthroplasty [42].
  • The hypothesis that ulnar fingers would have worse outcomes than radial fingers was not proven [44].
  • Sufficient correction of deformities in ulnar fingers is possible if adequate bone resection and realigning of the extensor mechanism are carefully performed [44].
  • The authors recommend using a surface replacing implant in fingers with preoperative axis deviations and correctable anatomical situation [46].
  • There is a higher risk of a second surgery when using a surface replacing implant in fingers with preoperative axis deviations and correctable anatomical situation [46].
  • Careful assessment of the donor toe and recipient finger anatomy followed by systematic and meticulous reconstruction may lead to improved functional outcomes in toe-to-finger vascularized joint transfers [47].
  • An IP joint fusion of the thumb or DIP joint fusion of the fingers can be performed safely with a low-profile plate fixation through a dorsal approach [50].
  • The extensor mechanism and central slip insertion to the middle phalanx must be reconstructed meticulously to improve joint motion and decrease extension lag in vascularized toe joint transfers [51].
  • Design of a lateral skin flap paddle allows better coverage of vessels and extensor repairs in vascularized toe joint transfers [51].
  • Selective arthrodesis is helpful in restoring hand function when normal painless joint function cannot be restored [52].
  • No border digit PIP joint arthrodesis angle was superior for grip and pinch strength [53].
  • Surgical intervention markedly improves hand and wrist function for many rheumatoid patients [54].

Classification

  • The SCARF classification system allows specification of every PIP joint dislocation type, even for non-hand specialists [32].
  • Treatment of PIP joint fracture dislocations is based on joint stability, fracture fragment size, and soft tissue injuries [55].

Clinical Presentation

  • Primary PIP joint arthroplasty utilization for osteoarthritis has increased, while revision PIP joint arthroplasty utilization has decreased [1].
  • Surgery performed better than collagenase enzymatic fasciotomy at early and 2-year follow-up in PIP joints affected by Dupuytren disease [2].
  • PIP joint arthrodesis has an excellent overall success rate and very few contraindications, making it an excellent option for surgical management of PIP joint arthritis [3].
  • The main goals of treatment for PIP joint complications are maintaining concentric reduction of the joint, restoring joint stability, and facilitating early range-of-motion exercises [4].
  • Reoperations following primary nonconstrained PIP joint arthroplasties are common, with extensor mechanism dysfunction being the most frequent cause [5].
  • Clinical outcomes for PIP joint replacements with pyrolytic carbon implants are variable despite substantially good survivorship [7].
  • PIP joint range of motion deteriorates over time in patients undergoing pyrolytic carbon hemiarthroplasty for PIP joint arthritis [8].
  • PIP joint denervation provides durable, effective pain relief with high patient satisfaction, despite osteoarthritis progression, supporting its consideration as a surgical option for symptomatic PIP joint osteoarthritis [11].
  • PIP joint implant arthroplasty is a good and reliable option for symptomatic PIP joint degenerative, post-traumatic, or inflammatory arthritis given the proper clinical setting [13].
  • Patients returned to work after a median of 8 weeks following PIP arthroplasty [14].
  • Periprosthetic joint infection is uncommon after MCP or PIP arthroplasties [15].
  • It is common for patients to experience a prolonged duration of swelling, stiffness, and dysfunction following PIP joint sprains [17].
  • Early recognition of joint instability is essential for adequate treatment of injuries of the PIP joint [21].
  • Timely diagnosis of PIP joint fracture dislocations is imperative, as they may rapidly develop fixed deformity if there is persistent incongruity of the joint [22].
  • Clinical results for PIP joint dislocations and fracture-dislocations vary and are often difficult to predict due to the complexity of fracture patterns and potential for sub-acute or chronic presentation [36].
  • PIP joint stiffness remains an unsolved problem in hand surgery, with poor prognosis in complex cases even after complete arthrolysis and tenolysis [37].

Investigations

  • Primary proximal interphalangeal joint arthroplasty (PIPA) utilization for osteoarthritis has increased, while revision PIPA has decreased [1].
  • Surgery performed better than collagenase at early and 2-year follow-up in PIP joints affected by Dupuytren Tubiana stage 1–3 [2].
  • Patients should be advised that PIPJ range of motion deteriorates over time following pyrolytic carbon hemiarthroplasty [8].
  • PIPJ implant arthroplasty is a good and reliable option for symptomatic PIPJ degenerative, post-traumatic or inflammatory arthritis given the proper clinical setting [13].
  • Periprosthetic joint infection (PJI) is uncommon after MCP or PIP arthroplasties [15].
  • Timely diagnosis is imperative for PIP joint fracture dislocations, especially if there is any persistent incongruity of the joint, as they may rapidly develop fixed deformity [22].
  • Open reduction of chronic untreated PIP joint dislocations can successfully achieve a functional range of motion with a stable joint [25].
  • Various techniques for PIP joint arthrodesis can achieve good functional results, but no optimal procedure has yet been found due to the diversity of available methods [26].
  • Pyrocarbon prosthesis replacement of the PIP joint reports good pain relief and stable radiographic integration at 5 years, with no late revisions or loosening observed, despite no improvement in range of motion [27].
  • Vascularized toe joint transfer reconstruction of the dysfunctional finger PIPJ is a valuable tool that should be considered in well-selected patients [56].

Treatment

  • Primary proximal interphalangeal joint implant (PIPA) utilization for osteoarthritis has increased, while revision PIPA has decreased [1].
  • Patients should be advised that PIPJ range of motion deteriorates over time [8].
  • Pyrocarbon PIPJ replacement is a safe and effective treatment for arthritis of the PIPJ, providing excellent pain relief and increasing the arc of motion by more than double the preoperative range [20].
  • External fixation is a simple and effective treatment modality for chronic traumatic PIP joint contractures with good predictable medium- to long-term results [23].
  • The CapFlex-PIP implant demonstrates favourable medium-term results in surface replacing arthroplasty of the proximal interphalangeal joint [24].
  • The Ascension pyrocarbon PIP joint replacement is an effective and reliable treatment for the painful, mobile arthritic PIP joint, maintaining useful motion and providing effective pain relief [43].
  • The reoperation rate after pyrocarbon PIP arthroplasty was 30% [49].

Complications

  • Revision proximal interphalangeal joint arthroplasty (PIPA) utilization has decreased [1].
  • Clinical outcomes for PIP joint replacements with pyrolytic carbon implants are variable [7].
  • Range of motion in PIP joints deteriorates over time following arthroplasty with pyrolytic carbon implants [8].
  • Salvage of a failed PIP joint arthroplasty may require arthrodesis or amputation [12].
  • Periprosthetic joint infection (PJI) is uncommon after primary metacarpophalangeal (MCP) or PIP arthroplasties [15].
  • Intraoperative periprosthetic fractures occur in approximately 5% of PIP joint arthroplasties [34].
  • Intraoperative periprosthetic fractures do not influence outcomes, including revision surgery, refracture rate, or other early complications [34].
  • The LPM PIP joint prosthesis had an unacceptable revision rate of 29% and a further 20% rate of adverse clinical and radiological outcomes at a maximum follow-up of 6 years [38].
  • Component loosening typical of earlier PIP and MCP joint surface replacement implant designs has not been a problem in initial reports [19].
  • Prolonged swelling, stiffness, and dysfunction are common following PIP joint sprains [17].

Recovery

  • Extensor mechanism dysfunction is the most frequent cause of reoperation following primary nonconstrained PIP joint arthroplasties [5].
  • Patients should be advised that PIP joint range of motion deteriorates over time [8].
  • High patient satisfaction is associated with pyrocarbon PIP joint arthroplasty [10].
  • Type of work and preoperative ability to perform work affect return to usual work following PIP joint arthroplasty for osteoarthritis [14].
  • Initial reports of PIP and MCP joint surface replacement implants are encouraging because component loosening typical of earlier designs has not been a problem to date [19].
  • Pyrocarbon prosthesis replacing the PIP joint provides good pain relief and stable radiographic integration at 5 years [27].
  • No late revisions or loosening were observed with pyrocarbon prosthesis replacing the PIP joint at 5 years [27].
  • Pyrocarbon prosthesis replacing the PIP joint showed no improvement in range of motion at 5 years [27].
  • Using night progressive static and daily dynamic orthoses as an exclusive treatment during the proliferative phase led to significant improvements in PIP joint active extension [57].
  • The improvement in PIP joint active extension from orthotic treatment did not correlate with increased function as perceived by the patient [57].
  • Early results of pyrolytic carbon surface replacement arthroplasty for posttraumatic, degenerative, and inflammatory arthritic disease of the PIP joint are encouraging [58].
  • Early results of pyrolytic carbon surface replacement arthroplasty for PIP joint disease compare favorably with prior reports of implants made of different materials [58].

Key Evidence

  • [L4] The data demonstrate an increased use of primary PIPA utilization for patients with OA, whereas revision PIPA decreased. [1] (10.1177/1558944719837009)
  • [L3] Surgery performed better than collagenase at early and 2-year follow-up in PIP joints and similarly in MCP joints. [2] (10.1007/s00402-018-3034-6)
  • [L5] PIPJ arthrodesis has very few contraindications, with an excellent overall success rate, making it an excellent option for surgical management of PIPJ arthritis. [3] (10.1016/j.hcl.2017.12.007)
  • [L5] The main goals of any treatment of a PIP joint complication are maintaining concentric reduction of the joint, restoring joint stability, and facilitating early range-of-motion exercises. [4] (10.1016/j.hcl.2017.12.014)
  • [L4] Reoperations following primary nonconstrained PIP joint arthroplasties are common, with extensor mechanism dysfunction being the most frequent cause. [5] (10.1016/j.jhsa.2011.06.002)
  • [L5] Maintaining motion and function following trauma and/or surgery of the PIP joint remains very challenging. [6] (10.1016/j.hcl.2017.12.003)
  • [L4] Despite substantially good survivorship, clinical outcomes for PIP joint replacements with pyrocarbon implants are variable. [7] (10.1302/2058-5241.2.160041)
  • [L4] Patients should be advised that PIPJ ROM deteriorates over time. [8] (10.1016/j.jhsa.2023.11.007)
  • [L4] The survival of pyrocarbon PIP joint arthroplasty was 85% at 5 years of follow-up, with high patient satisfaction. [10] (10.1016/j.jhsa.2012.02.012)
  • [L4] PIP joint denervation provides durable, effective pain relief with high patient satisfaction, despite osteoarthritis progression, supporting its consideration as a surgical option for symptomatic PIP joint osteoarthritis. [11] (10.1016/j.jhsa.2026.01.033)
  • [L5] Ultimate salvage for the failed PIP joint arthroplasty may require arthrodesis or even amputation. [12] (10.1016/j.hcl.2017.12.011)
  • [L4] PIPJ implant arthroplasty is a good and reliable option for symptomatic PIPJ degenerative, post-traumatic or inflammatory arthritis given the proper clinical setting. [13] (10.1177/17531934241265837)
  • [L3] Patients returned to work after a median of 8 weeks following PIP arthroplasty. [14] (10.1177/15589447221141485)
  • [L4] PJI is uncommon after MCP or PIP arthroplasties. [15] (10.1016/j.jhsa.2024.12.008)
  • [L1] Treatment of the long finger may be a relative contraindication to PIPJ arthroplasty. [16] (10.1177/1558944718791186)
  • [L4] It is common for patients to experience a prolonged duration of swelling, stiffness, and dysfunction following PIP joint sprains. [17] (10.1016/j.jhsa.2023.01.025)
  • [L4] Reoperations following primary non-constrained PIP arthroplasties are common. [18] (10.1016/s0363-5023(11)60049-x)
  • [L5] Initial reports of PIP and MCP joint surface replacement implants are encouraging, particularly because component loosening typical of earlier designs has not been a problem to date. [19] (10.5435/00124635-200309000-00002)
  • [L4] Pyrocarbon PIPJ replacement is a safe and effective treatment for arthritis of the PIPJ, providing excellent pain relief and increasing the arc of motion by more than double the preoperative range. [20] (10.1177/1753193411434053)
  • [L5] Early recognition of joint instability is essential for adequate treatment of injuries of the PIP joint. [21] (10.5435/00124635-200011000-00006)
  • [L5] Timely diagnosis is imperative, especially if there is any persistent incongruity of the joint, as fracture dislocations of the PIP joint may rapidly develop fixed deformity, leaving an athlete with a poor outlook for complete correction. [22] (10.1016/j.hcl.2012.05.036)
  • [L4] External fixation is a simple and effective treatment modality for chronic traumatic PIP joint contractures with good predictable medium- to long-term results. [23] (10.1016/j.jhsa.2013.07.007)
  • [L4] The CapFlex-PIP implant demonstrates favourable medium-term results in surface replacing arthroplasty of the proximal interphalangeal joint. [24] (10.1177/1753193420977244)
  • [L4] This surgical technique of open reduction of chronic untreated PIP joint dislocations can successfully achieve a functional range of motion with a stable joint. [25] (10.1016/j.jhsa.2020.07.002)
  • [Paper] The review concludes that while various techniques for PIP joint arthrodesis can achieve good functional results, no optimal procedure has yet been found due to the diversity of available methods. [26] (10.1055/a-0833-8729)
  • [L4] The study reports good pain relief and stable radiographic integration at 5 years, with no late revisions or loosening observed, despite no improvement in range of motion. [27] (10.1177/1753193413479527)
  • [L5] Proper biomechanics of a joint must be restored to achieve full, functional range of motion. [28] (10.1016/j.hcl.2017.12.008)
  • [L5] Despite the wealth of knowledge regarding the anatomy of the PIPJ, it remains a subject of ongoing investigation, and evolving understanding of its biomechanical properties will continue to improve treatment and reconstructive designs. [29] (10.1016/j.hcl.2017.12.002)
  • [Paper] Hand therapy programs for the proximal interphalangeal joint must address the specific disorder, timing of injury, and phases of healing to prevent stiffness and dysfunction. [30] (10.1016/j.hcl.2018.01.001)
  • [L5] Stiffness of the PIP joint is a challenging problem that may be successfully treated under the guidance of a hand therapist. [31] (10.1016/j.jhsa.2015.06.118)
  • [L2] Even other than hand specialists can specify the type of every PIP joint dislocation by using the SCARF classification and will have better understanding of each case. [32] (10.1016/j.jos.2019.08.007)
  • [L5] Suboptimal treatment of intra-articular fractures typically leads to functional impairment of the hand. [33] (10.1177/1753193414559464)
  • [L3] Intraoperative fractures occur in about 5% of PIP joint arthroplasties and do not appear to influence outcomes, including revision surgery, refracture rate, or other early complications. [34] (10.1016/j.jhsa.2015.06.101)
  • [L2] Although past experiences have indicated that it is more difficult to maintain posture for the ring and little fingers due to the deforming forces, it is certainly possible if attention to adequate bone resection and realigning of the extensor mechanism is carefully taken during the surgical procedure. [35] (10.1016/s0363-5023(09)60133-7)
  • [L5] Clinical results for PIP joint dislocations and fracture-dislocations vary and are often difficult to predict due to the complexity of fracture patterns and potential for sub-acute or chronic presentation. [36] (10.1177/17531934231183259)
  • [L5] PIP joint stiffness remains an unsolved problem in hand surgery, with poor prognosis in complex cases even after complete arthrolysis and tenolysis. [37] (10.1177/17531934221143690)
  • [L4] The revision rate of 29% and a further 20% rate of adverse clinical and radiological outcomes for the LPM PIPJ prosthesis at a maximum follow-up of 6 years is unacceptable. [38] (10.1177/1753193408094920)
  • [L4] However, implant fractures did not significantly affect upper limb function. [39] (10.1016/j.jhsa.2024.01.009)
  • [L3] Establishment of normative values may enable surgeons to explain the lack of progress after surgical joint release, determine progress with hand therapy, and choose the optimal timing of surgical intervention once soft-tissue equilibrium is achieved. [40] (10.1016/j.jhsg.2025.100748)
  • [L4] Simulated arthrodesis of the middle finger affected the grip strength more than that of the ring finger. [41] (10.1007/s00402-021-04317-w)
  • [L3] Patients with greater hand function preoperatively may be at higher risk of revision surgery. [42] (10.1177/1558944719831236)
  • [L4] The Ascension pyrocarbon PIP joint replacement is an effective and reliable treatment for the painful, mobile arthritic PIP joint, maintaining useful motion and providing effective pain relief. [43] (10.1177/1753193414566552)
  • [L2] The hypothesis that ulnar fingers would have worse outcomes than radial fingers was not proven; sufficient correction of deformities in ulnar fingers is possible if adequate bone resection and realigning of the extensor mechanism are carefully performed. [44] (10.1016/j.jhsa.2009.06.029)
  • [L4] The authors recommend using a surface replacing implant in fingers with preoperative axis deviations and correctable anatomical situation, bearing in mind the higher risk of a second surgery. [46] (10.1007/s00402-020-03663-5)
  • [L4] Careful assessment of the donor toe and recipient finger anatomy followed by systematic and meticulous reconstruction may lead to improved functional outcomes. [47] (10.1177/1558944720988081)
  • [Paper] The reoperation rate after pyrocarbon PIP arthroplasty was 30%. [49] (10.1055/s-0040-1709088)
  • [L4] An IP joint fusion of the thumb or DIP joint fusion of the fingers can be performed safely with a low-profile plate fixation through a dorsal approach. [50] (10.1016/j.jhsa.2018.03.049)
  • [L4] The extensor mechanism and central slip insertion to the middle phalanx must be reconstructed meticulously to improve joint motion and decrease extension lag, and design of a lateral skin flap paddle to better cover vessels and allow extensor repairs. [51] (10.1177/1753193419857475)
  • [L4] Selective arthrodesis is helpful in restoring hand function when normal painless joint function cannot be restored. [52] (10.1016/s0039-6109(16)36053-4)
  • [L4] No border digit PIP joint arthrodesis angle was superior for grip and pinch strength. [53] (10.1016/j.jhsa.2019.11.008)
  • [L5] Surgical intervention markedly improves hand and wrist function for many rheumatoid patients. [54] (10.5435/jaaos-d-20-00102)
  • [L5] This article serves as a reference for the current understanding and best practices in treating PIP joint fracture dislocations, emphasizing that treatment is based on joint stability, fracture fragment size, and soft tissue injuries. [55] (10.1016/j.hcl.2017.12.005)
  • [L4] Vascularized toe joint transfer reconstruction of the dysfunctional finger PIPJ is a valuable tool that should be considered in well-selected patients. [56] (10.1016/j.hcl.2017.12.010)
  • [L1] Using night progressive static and daily dynamic orthoses as an exclusive treatment during the proliferative phase led to significant improvements in the PIP joint active extension, but the improvement did not correlate with increased function as perceived by the patient. [57] (10.1016/j.jhsa.2015.01.005)
  • [L5] Early results of pyrolytic carbon surface replacement arthroplasty for posttraumatic, degenerative, and inflammatory arthritic disease of the PIP joint are encouraging and compare favorably with prior reports of implants made of different materials. [58] (10.5435/00124635-200703000-00009)

References

[1] Trends in Primary Proximal Interphalangeal Joint System and Revisions for Osteoarthritis of the Hand in the Medicare Database. HAND. 2019. DOI: 10.1177/1558944719837009

[2] Range of motion, postoperative rehabilitation and patient satisfaction in MCP and PIP joints affected by Dupuytren Tubiana stage 1–3: collagenase enzymatic fasciotomy or limited fasciectomy? A clinical study in 52 patients. Archives of Orthopaedic and Trauma Surgery. 2018. DOI: 10.1007/s00402-018-3034-6

[3] Proximal Interphalangeal Joint Fusion. Hand Clinics. 2018. DOI: 10.1016/j.hcl.2017.12.007

[4] Complications of Proximal Interphalangeal Joint Injuries. Hand Clinics. 2018. DOI: 10.1016/j.hcl.2017.12.014

[5] Reoperations Following Proximal Interphalangeal Joint Nonconstrained Arthroplasties. The Journal of Hand Surgery. 2011. DOI: 10.1016/j.jhsa.2011.06.002

[6] Surgical Exposure of the Proximal Interphalangeal Joint. Hand Clinics. 2018. DOI: 10.1016/j.hcl.2017.12.003

[7] Proximal interphalangeal (PIP) joint replacements with pyrolytic carbon implants in the hand. EFORT Open Reviews. 2017. DOI: 10.1302/2058-5241.2.160041

[8] Pyrolytic Carbon Hemiarthroplasty for Proximal Interphalangeal Joint Arthritis, Long-Term Follow-Up. The Journal of Hand Surgery. 2024. DOI: 10.1016/j.jhsa.2023.11.007

[10] Pyrocarbon Proximal Interphalangeal Joint Arthroplasty: Minimum Two-Year Follow-Up. The Journal of Hand Surgery. 2012. DOI: 10.1016/j.jhsa.2012.02.012

[11] Long-term Survival of Proximal Interphalangeal Joint Denervation of the Hand: Time-to-Event Analysis. The Journal of Hand Surgery. 2026. DOI: 10.1016/j.jhsa.2026.01.033

[12] Salvaging a Failed Proximal Interphalangeal Joint Implant. Hand Clinics. 2018. DOI: 10.1016/j.hcl.2017.12.011

[13] Proximal interphalangeal joint arthroplasty: current trends and evidence-based practice. Journal of Hand Surgery (European Volume). 2024. DOI: 10.1177/17531934241265837

[14] Type of Work and Preoperative Ability to Perform Work Affect Return to Usual Work Following Proximal Interphalangeal Joint Arthroplasty for Osteoarthritis. HAND. 2022. DOI: 10.1177/15589447221141485

[15] Incidence and Presentation of Periprosthetic Joint Infection After Primary Metacarpophalangeal and Proximal Interphalangeal Arthroplasty. The Journal of Hand Surgery. 2025. DOI: 10.1016/j.jhsa.2024.12.008

[16] Prosthetic Arthroplasty of Proximal Interphalangeal Joints for Treatment of Osteoarthritis and Posttraumatic Arthritis: Systematic Review and Meta-Analysis Comparing the Three Ulnar Digits With the Index Finger. HAND. 2018. DOI: 10.1177/1558944718791186

[17] Swelling, Stiffness, and Dysfunction Following Proximal Interphalangeal Joint Sprains. The Journal of Hand Surgery. 2024. DOI: 10.1016/j.jhsa.2023.01.025

[18] Reoperations following Proximal Interphalangeal Joint Unconstrained Arthroplasty. The Journal of Hand Surgery. 2011. DOI: 10.1016/s0363-5023(11)60049-x

[19] New-Generation Implant Arthroplasties of the Finger Joints. Journal of the American Academy of Orthopaedic Surgeons. 2003. DOI: 10.5435/00124635-200309000-00002

[20] Pyrocarbon proximal interphalangeal joint arthroplasty: outcomes of a cohort study. Journal of Hand Surgery (European Volume). 2011. DOI: 10.1177/1753193411434053

[21] Fractures of the Proximal Interphalangeal Joint. Journal of the American Academy of Orthopaedic Surgeons. 2000. DOI: 10.5435/00124635-200011000-00006

[22] Proximal Interphalangeal Joint Fracture Dislocations. Hand Clinics. 2012. DOI: 10.1016/j.hcl.2012.05.036

[23] Distraction for Proximal Interphalangeal Joint Contractures: Long-Term Results. The Journal of Hand Surgery. 2013. DOI: 10.1016/j.jhsa.2013.07.007

[24] Surface replacing arthroplasty of the proximal interphalangeal joint using the CapFlex-PIP implant: a prospective study with 5-year outcomes. Journal of Hand Surgery (European Volume). 2020. DOI: 10.1177/1753193420977244

[25] Open Reduction of Neglected Dislocations of the Proximal Interphalangeal Joint. The Journal of Hand Surgery. 2020. DOI: 10.1016/j.jhsa.2020.07.002

[26] Die Arthrodese des Fingermittelgelenkes: eine Literaturanalyse. Handchirurgie · Mikrochirurgie · Plastische Chirurgie. 2019. DOI: 10.1055/a-0833-8729

[27] Ten years’ experience with a pyrocarbon prosthesis replacing the proximal interphalangeal joint. A prospective clinical and radiographic follow-up. Journal of Hand Surgery (European Volume). 2013. DOI: 10.1177/1753193413479527

[28] Advances in Proximal Interphalangeal Joint Arthroplasty. Hand Clinics. 2018. DOI: 10.1016/j.hcl.2017.12.008

[29] Anatomy and Biomechanics of the Finger Proximal Interphalangeal Joint. Hand Clinics. 2018. DOI: 10.1016/j.hcl.2017.12.002

[30] Therapy Concepts for the Proximal Interphalangeal Joint. Hand Clinics. 2018. DOI: 10.1016/j.hcl.2018.01.001

[31] Hand Therapy Modalities for Proximal Interphalangeal Joint Stiffness. The Journal of Hand Surgery. 2015. DOI: 10.1016/j.jhsa.2015.06.118

[32] Ratio of dislocation types of the proximal interphalangeal joint of the fingers: A new classification system for initial therapy. Journal of Orthopaedic Science. 2019. DOI: 10.1016/j.jos.2019.08.007

[33] Management of difficult intra-articular fractures or fracture dislocations of the proximal interphalangeal joint. Journal of Hand Surgery (European Volume). 2014. DOI: 10.1177/1753193414559464

[34] Intraoperative Periprosthetic Fractures in Proximal Interphalangeal Joint Arthroplasty. The Journal of Hand Surgery. 2015. DOI: 10.1016/j.jhsa.2015.06.101

[35] Outcomes of Silicone Arthroplasty Stratified by Fingers for the Rheumatoid Metacarpophalangeal Joints. The Journal of Hand Surgery. 2009. DOI: 10.1016/s0363-5023(09)60133-7

[36] Proximal interphalangeal joint dislocations and fracture-dislocations. Journal of Hand Surgery (European Volume). 2023. DOI: 10.1177/17531934231183259

[37] The stiff proximal interphalangeal joint – an unsolved problem?. Journal of Hand Surgery (European Volume). 2023. DOI: 10.1177/17531934221143690

[38] A Report on the Early Failure of the LPM Proximal Interphalangeal Joint Replacement. Journal of Hand Surgery (European Volume). 2008. DOI: 10.1177/1753193408094920

[39] Long-Term Implant Fracture Rates Following Silicone Metacarpophalangeal Joint Arthroplasty in Rheumatoid Arthritis. The Journal of Hand Surgery. 2024. DOI: 10.1016/j.jhsa.2024.01.009

[40] A Novel Technique to Assess Soft-Tissue Redundancy Over the Proximal Interphalangeal Joint. Journal of Hand Surgery Global Online. 2025. DOI: 10.1016/j.jhsg.2025.100748

[41] The impact of various simulated arthrodesis angles of the proximal interphalangeal joint of the ring and middle finger on grip strength. Archives of Orthopaedic and Trauma Surgery. 2022. DOI: 10.1007/s00402-021-04317-w

[42] Factors Associated With Reoperation After Silicone Metacarpophalangeal Joint Arthroplasty in Patients With Inflammatory Arthritis. HAND. 2019. DOI: 10.1177/1558944719831236

[43] Pyrocarbon proximal interphalangeal joint arthroplasty: a medium to long term follow-up of a single surgeon series. Journal of Hand Surgery (European Volume). 2015. DOI: 10.1177/1753193414566552

[44] Outcomes of Silicone Arthroplasty for Rheumatoid Metacarpophalangeal Joints Stratified by Fingers. The Journal of Hand Surgery. 2009. DOI: 10.1016/j.jhsa.2009.06.029

[46] Complications after surface replacing and silicone PIP arthroplasty: an analysis of 703 implants. Archives of Orthopaedic and Trauma Surgery. 2020. DOI: 10.1007/s00402-020-03663-5

[47] Toe-to-Finger Vascularized Joint Transfers for Proximal Interphalangeal Joint Reconstruction: A Systematic Review. HAND. 2021. DOI: 10.1177/1558944720988081

[49] Factors Associated with Reoperation after Pyrocarbon Proximal Interphalangeal Joint Arthroplasty for the Arthritic Joint: A Retrospective Cohort Study. Journal of Hand and Microsurgery. 2021. DOI: 10.1055/s-0040-1709088

[50] Dorsal Plate Fixation for Distal Interphalangeal Joint Arthrodesis of the Fingers and Thumb. The Journal of Hand Surgery. 2018. DOI: 10.1016/j.jhsa.2018.03.049

[51] Technical keys in maximizing finger proximal interphalangeal joint motion after vascularized toe joint transfers. Journal of Hand Surgery (European Volume). 2019. DOI: 10.1177/1753193419857475

[52] Arthrodesis of Finger Joints. Surgical Clinics of North America. 1960. DOI: 10.1016/s0039-6109(16)36053-4

[53] The Optimal Position for Arthrodesis of the Proximal Interphalangeal Joints of the Border Digits. The Journal of Hand Surgery. 2020. DOI: 10.1016/j.jhsa.2019.11.008

[54] Collaboration in Hand Surgery: Experiences From Silicone Arthroplasty in Rheumatoid Arthritis, Finger Replantation and Amputation Challenges in Assessing Impairment, Satisfaction, and Effectiveness, Wrist and Radius Injury Surgical Trial, and Surgery of the Ulnar Nerve. Journal of the American Academy of Orthopaedic Surgeons. 2020. DOI: 10.5435/jaaos-d-20-00102

[55] Management of Proximal Interphalangeal Joint Fracture Dislocations. Hand Clinics. 2018. DOI: 10.1016/j.hcl.2017.12.005

[56] Microvascular Toe Joint for Proximal Interphalangeal Joint Replacement. Hand Clinics. 2018. DOI: 10.1016/j.hcl.2017.12.010

[57] Treatment of Proximal Interphalangeal Joint Flexion Contracture: Combined Static and Dynamic Orthotic Intervention Compared With Other Therapy Intervention: A Randomized Controlled Trial. The Journal of Hand Surgery. 2015. DOI: 10.1016/j.jhsa.2015.01.005

[58] Proximal Interphalangeal Joint Arthroplasty. Journal of the American Academy of Orthopaedic Surgeons. 2007. DOI: 10.5435/00124635-200703000-00009

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International


Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees


Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.